2023
DOI: 10.1007/s11605-022-05476-w
|View full text |Cite
|
Sign up to set email alerts
|

Tailoring Adjuvant Chemotherapy to Biologic Response Following Neoadjuvant Chemotherapy Impacts Overall Survival in Pancreatic Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 36 publications
0
0
0
Order By: Relevance
“…This reflects current clinical care, in which baseline CA 19-9 values are increasingly incorporated in the decision-making process regarding upfront surgery or (neo)adjuvant treatment strategies. 4 6 In patients with neoadjuvant treatment, CA 19-9 levels dropped substantially after treatment. Postsurgery, CA 19-9 levels did not show clear differences between the 4 groups.…”
mentioning
confidence: 99%
“…This reflects current clinical care, in which baseline CA 19-9 values are increasingly incorporated in the decision-making process regarding upfront surgery or (neo)adjuvant treatment strategies. 4 6 In patients with neoadjuvant treatment, CA 19-9 levels dropped substantially after treatment. Postsurgery, CA 19-9 levels did not show clear differences between the 4 groups.…”
mentioning
confidence: 99%